Pathophysiology of Ovarian Function in the Human Female

Slides:



Advertisements
Similar presentations
Physiology of menstruation
Advertisements

Menstrual cycle By: Dr. Zeinab Hakim
Polycystic Ovarian Syndrome (PCOS)
The Cycle Steven L. Young MD, PhD Obstetrics & Gynecology UNC School of Medicine Mystery Menstrual.
Marijan Pašalić Mentor: A. Žmegač Horvat
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
Emily Bartlett Katrina Bush
PCOS Polycystic Ovary Syndrome
The Metabolic Syndrome in PCOS. An international consensus group of the European Society for Human Reproduction and Embryology and the American Society.
Anti-Mullerian Hormone in the pathophysiology of PCOS Roy Homburg Homerton University Hospital, London & Barzilai Medical Centre, Ashkelon, Israel.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Ovaries and the Fertility Cycle
Copyright © 2006 by Elsevier, Inc. Male Reproductive System Figure 80-1 Guyton & Hall.
Menstrual Cycle. Menstruation is also called Menstrual bleeding, Menses, a period. The flow of menses normally serves as a sign that a woman has not become.
Reproductive Physiology Lecture 1 Hypothalamic-Pituitary-Gonadal axis.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
Which came first - the chicken or the egg? Physiology of Reproduction Jennifer McDonald DO.
Objectives By the end of this lecture, you should be able to: 1. List the hormones of female reproduction and describe their physiological functions 2.
ANOVULATION CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Sherwood’s Human Physiology th Ed. & th Ed. Follicular Phase During the first few days of each ovarian cycle the concentrations of LH and.
OVARIAN CYCLE.
PROFESSOR ZEINAB ABOTALIB Consultant Obstetrics & Gynaecology and infertility.
Physiopathology and diagnosis of PCOS Ertan SARIDOĞAN Consultant in Reproductive Medicine and Minimal Access Surgery University College London Hospitals.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Biology 12 THE FEMALE MENSTRUAL CYCLE.  The menstrual cycle is the term for the physiological changes that can occur in fertile women for the purposes.
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
Centre For Reproductive Biology University of Edinburgh
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Female reproductive physiology
Chapter 46.4 and 46.5 Animal Reproduction.
Reproductive System-L3
Department of Gynecology and Obstetrics
Menotropins Drugbank ID : DB00032
© SSER Ltd..
Unit B: Reproduction and Development
Lecture 2 Physiology of ovarian cycle
Polycystic ovarian syndrome Obesity and Insulin resistance
Reproduction-Related Disorders
N.Cem FIÇICIOĞLU, M.D., Ph.D.AA.,MBA. Professor and Director
Biomarkers of ovarian cancer and cysts
Lecture 1 Hypothalamic and pituitary gonadal axis
Biomarkers of ovarian cancer and cysts
IN THE NAME OF GOD.
Physiology of the menstrual cycle
Chapter 17 Female Reproduction.
Reproductive Anatomy of Female
Menstruation IF fertilization does NOT take place
Stress and the Reproductive System
Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles  Almudena Veiga-Lopez,
OVARIAN CYCLE By Dr Samina Anjum.
CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA
Female and Male Reproductive Systems
Aging and Reproduction
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Chapter 26 Copyright © 2016 F.A. Davis Company.
Organismal Development Part 4
Genetic Differentiation 1. H-Y Antigen- Histocompatability Y antigen 1. Male specific antigen present on the surfaces of cells XY = H-Y antigen.
Menstrual cycle Lecture 2.
Gonadotropin Signaling in the Ovary
Control of the Menstrual Cycle
Menstrual cycle and Ovulation
Invited commentary: A single nucleotide polymorphism in BMP15 is associated with high response to controlled ovarian hyperstimulation  Ronit Abir, Benjamin.
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
The Female Menstrual Cycle
Ontogeny of the ovary in polycystic ovary syndrome
Testicular Development
Chapter 42 Parturition © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition.
Organismal Development Part 4
Nat. Rev. Nephrol. doi: /nrneph
Presentation transcript:

Pathophysiology of Ovarian Function in the Human Female Chapter 29 Pathophysiology of Ovarian Function in the Human Female © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.1 The decline in follicle number in the human ovary with age. Source: Data compiled from various sources. 48–51 © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.2 Stages of human follicle development. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.3 Possible mechanisms to provide inhibition of activation of primordial follicles in the mammalian ovary. (A) Inhibitory signal from grow- ing follicles; (B) primordial follicles produce a local factor (or factors) that inhibits their neighbors from activating; (C) an inhibitory factor produced by the ovarian surface epithelium. 60 © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.4 Neighboring primordial follicles inhibit activa- tion of follicle growth. The proportion of follicles that are growing is inversely related to the number of primordial follicles within a 10 μm radius, suggesting that neighboring primordial follicles inhibit each other from initiating growth (juvenile mouse ovary day P8). 60 © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.5 The human menstrual cycle. Source: From Ref. 66. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.6 Mathematical modeling of growth trajec- tory of follicles in (A) ovulatory and (B) anovulatory poly- cystic ovary. Time and maturity are in arbitrary units. By applying Lacker’s model, 74 it is suggested that in anovula- tory PCOS: (1) the primary cause of follicular dysfunction is at the level of the ovary, rather than the pituitary, and is characterized by variable responsiveness of follicles to FSH; (2) arrested follicles have different properties from healthy follicles; (3) the abnormal response to gonadotropins is best characterized by enhanced sensitivity to FSH (and LH) in a subpopulation of follicles; and (4) those follicles that are hyperresponsive to gonadotropins produce a high enough concentration of circulating estradiol to suppress FSH to a level that is too low to encourage further development of healthy follicles in the cohort. See also the section Etiology and Pathogenesis of PCOS: Anovulation, Androgen Excess, and Disordered Follicle Development. Source: Data are from Ref. 73 and Ref. 63. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.7 LH secretory patterns in (A) a normal woman with regular menses, studied in the midfollicular phase; (B) a woman with partially recovered weight loss-related amenorrhea; and (C) a woman with a persistently low BMI. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.8 Heterogeneity of pulsatile LH secretion in women with PCOS showing (A) elevated mean LH and high-amplitude pulses; (B) levels of LH that fall into the normal range (2–12 U/L) (although still above the mean level in normal subjects), with occa- sional high-amplitude pulses; and (C) normal mean LH and normal pulse amplitude. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.9 Proposed developmental etiol- ogy of polycystic ovary syndrome (PCOS). 162,163 It is suggested that the ovary is genetically predis- posed to hypersecrete androgens, perhaps as early as intrauterine life but certainly during the activa- tion of the hypothalamic–pituitary–ovarian axis that occurs transiently in infancy and in a sustained manner at puberty. Higher than normal circulat- ing levels of testosterone “program” the hypotha- lamic–pituitary unit to produce high tonic levels of luteinizing hormone (LH), and also amplify the physiological insulin resistance of puberty. Higher than normal concentrations of LH and insulin fur- ther enhance ovarian androgen production and may contribute to the mechanism of anovulation. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.10 Production of androstenedione (median, range) by human theca cells in primary culture. Greatly increased androgen production by cells from women with polycystic ovaries is shown. Note the logarithmic scale of the Y-axis. LH stimulated androstene- dione production by both normal (1.7-fold) and PCO theca (1.8-fold, p < 0.005). Source: Adapted from Ref. 182. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.11 Serum LH concentrations in women with poly- cystic ovaries on ultrasound who were studied in the follicular phase of spontaneous cycles or whilst taking the combined oral contracep- tive (COC). Note the reduced suppression of LH (p < 0.05) in women with PCOS during COC treatment. Source: Data adapted from a study of the prevalence of PCOS in women in the general population by Ref. 196. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.12 Proposed mechanisms for increased density of preantral follicles in women with PCOS. (A) Possible mechanisms for increased initial density are (i) more cell division in PGCs leading to (ii) increased endowment of primordial; and/or (B) increased survival of preantral follicles. Source: Adapted from Ref. 200. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.13 Granulosa cell proliferation is increased in pren- tral follicles of women with PCOS. Proportion of preantral ovarian follicles expressing the proliferation marker mini-chromosome main- tenance protein 2 (MCM2) in women with normal ovaries, and two groups of women with PCOS—those with regular ovulatory cycles (ovPCO) and those with anovulation (anovPCO) (*p = 0.03). Source: Data from Ref. 207. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.14 Relationship between granulosa cell number and oocyte diameter in preantral follicles from normal and polycys- tic ovaries. Note the discordant pattern in follicles from women with anovulation and PCOS. 207 © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.15 Sum of serum insulin concentrations during a standard 75 gm oral glucose tolerance test (median and interquartile range), and insulin sensitivity (mean ± SEM) in three groups of weight- matched subjects: women with normal ovaries and regular cycles; women with polycystic ovaries, androgen excess, and regular cycles (ovPCO); and women androgen excess and anovulation (anovPCO). Hyperinsulinemia and insulin resistance are features of anovPCO but not ovPCO. Source: Data from Ref. 190. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition

FIGURE 29.16 Mean serum LH (filled circles, day −20) and FSH (filled squares, day −20) concentrations before treatment; and LH (filled circles with dashed lines), FSH (filled squares with solid line), and estra- diol (filled triangles with dotted line) during induced mono-ovulatory cycles in women with anovulatory PCOS treated with low-dose FSH. Serum FSH levels are raised to the normal early follicular phase range but show a fall toward day 0 (days normalized to start of the LH surge or injection with human chorionic gonadotropin), indicating preserva- tion of the normal negative feedback control of FSH in the late follicular phase despite a fixed dose of exogenous FSH from day 10 onward. Note also the suppression of high LH levels during the late follicular phase. © 2015, Elsevier, Inc., Plant and Zeleznik, Knobil and Neill's Physiology of Reproduction, Fourth Edition